Latest news
Consensus Analysis | Astra Zeneca | 6 August 2026 - BiostockBiostock · Thu, 06 Aug 2026 14:57:19 GMTAstraZeneca Targets $400B Bristol Myers Squibb Merger Twelve Years After Spurning Pfizer - Tech TimesTech Times · Sun, 02 Aug 2026 21:39:28 GMTAstraZeneca Cancer Drug Targets Up to $5 Billion in Sales - GuruFocusGuruFocus · Tue, 28 Jul 2026 17:02:46 GMTAstraZeneca's drug pipeine is splitting opinion among City analysts - Proactive financial newsProactive financial news · Tue, 28 Jul 2026 13:32:00 GMTAstraZeneca's $2.63 Earnings Beat Supports $80 Billion Revenue Target - TradingViewTradingView · Mon, 27 Jul 2026 19:16:08 GMTSoriot soothes investor fears as AstraZeneca sticks to $80bn goal - The TimesThe Times · Mon, 27 Jul 2026 16:35:24 GMTAstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth - WSJWSJ · Mon, 27 Jul 2026 07:00:00 GMTAstraZeneca profit beat, bullish tone ease worries over drug pipeline - ReutersReuters · Mon, 27 Jul 2026 07:00:00 GMT